Pacira BioSciences Inc (PCRX)
16.57
-0.03
(-0.18%)
USD |
NASDAQ |
Nov 01, 16:00
16.55
-0.02
(-0.12%)
After-Hours: 20:00
Pacira BioSciences Debt to Equity Ratio: 0.6702 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.6702 |
| March 31, 2024 | 0.5832 |
| December 31, 2023 | 0.6004 |
| September 30, 2023 | 0.6308 |
| June 30, 2023 | 0.6828 |
| March 31, 2023 | 0.721 |
| December 31, 2022 | 0.8896 |
| September 30, 2022 | 0.9711 |
| June 30, 2022 | 0.9987 |
| March 31, 2022 | 1.301 |
| December 31, 2021 | 1.436 |
| September 30, 2021 | 0.6706 |
| June 30, 2021 | 0.6918 |
| March 31, 2021 | 0.7206 |
| December 31, 2020 | 0.7466 |
| September 30, 2020 | 0.7807 |
| June 30, 2020 | 0.8094 |
| March 31, 2020 | 0.829 |
| December 31, 2019 | 0.8622 |
| September 30, 2019 | 0.8727 |
| June 30, 2019 | 0.8728 |
| March 31, 2019 | 0.8987 |
| December 31, 2018 | 0.9057 |
| September 30, 2018 | 0.9534 |
| June 30, 2018 | 0.9762 |
| Date | Value |
|---|---|
| March 31, 2018 | 1.005 |
| December 31, 2017 | 0.9893 |
| September 30, 2017 | 1.031 |
| June 30, 2017 | 1.033 |
| March 31, 2017 | 0.9857 |
| December 31, 2016 | 0.4966 |
| September 30, 2016 | 0.5023 |
| June 30, 2016 | 0.4659 |
| March 31, 2016 | 0.4652 |
| December 31, 2015 | 0.4764 |
| September 30, 2015 | 0.5019 |
| June 30, 2015 | 0.532 |
| March 31, 2015 | 0.5659 |
| December 31, 2014 | 0.6024 |
| September 30, 2014 | 0.6582 |
| June 30, 2014 | 0.6828 |
| March 31, 2014 | 2.800 |
| December 31, 2013 | 2.399 |
| September 30, 2013 | 1.994 |
| June 30, 2013 | 1.638 |
| March 31, 2013 | 1.374 |
| December 31, 2012 | 0.3825 |
| September 30, 2012 | 0.3099 |
| June 30, 2012 | 0.261 |
| March 31, 2012 | 0.6712 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5832
Minimum
Mar 2024
1.436
Maximum
Dec 2021
0.8209
Average
0.7466
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Cyclo Therapeutics Inc | -0.5292 |
| Revance Therapeutics Inc | -3.319 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.647B |
| Total Liabilities (Quarterly) | 767.54M |
| Shareholders Equity (Quarterly) | 879.28M |
| Current Ratio | 6.821 |
| Net Debt Paydown Yield | -0.54% |